News

Ben Rowe Steps Up as CEO of KHP Capital Partners

Ben Rowe Steps Up as CEO of KHP Capital Partners

Ben Rowe Takes the Helm as CEO of KHP Capital Partners

KHP Capital Partners has made an exciting announcement regarding its leadership. Ben Rowe, Co-Founder and Managing Partner of KHP, will officially step into the role of Chief Executive Officer. This change comes as part of a well-planned succession strategy aimed at ensuring a smooth transition while continuing to guide the firm toward future growth.

The Journey of KHP Capital Partners

Founded in 2015, KHP Capital Partners has made significant strides in the real estate private equity sector, focusing primarily on acquiring and developing lifestyle hotels. Under the partnership of Rowe and his colleagues Mike Depatie and Joe Long, KHP has amassed a remarkable portfolio, managing approximately $1 billion in equity and overseeing investments in 20 unique properties.

Ben Rowe's Background and Achievements

Rowe’s journey in the hospitality industry began at Kimpton Hotels and Restaurants in 2003, where he joined Depatie and Long. As the Chief Financial Officer from 2008 to 2015, he played an integral role in transforming Kimpton into a leading lifestyle hotel brand. After the sale of Kimpton to InterContinental Hotels Group, the trio launched KHP, marking a new chapter in their careers.

Support from Fellow Partners

Joe Long, a fellow Co-Founder and Managing Partner, expressed immense confidence in Rowe’s capabilities. Long stated, "I have worked closely with Ben for the last 22 years, and he is one of the most dedicated and knowledgeable individuals I have encountered in my career. His vision, detail-oriented nature, and commitment to company culture make him a stellar leader for KHP." This camaraderie and mutual respect highlight the supportive framework within which KHP operates.

A Transition for Future Growth

Rowe's appointment as CEO is not only a personal milestone but also part of a broader succession plan aimed at nurturing future leaders. This strategy ensures that the insights and expertise of the founding partners continue to influence KHP's direction. In line with this plan, Jeff Stulmaker was appointed as Chief Investment Officer in early 2022, further strengthening the leadership team.

Future Plans and Vision

Ben Rowe aims to build upon KHP’s legacy of success. "I am eager to enhance the foundation of trust and investment excellence that KHP has established over the past decade," he remarked. Rowe emphasized the importance of KHP's team and its strong relationships with institutional partners, positioning the firm to thrive in today’s dynamic investment landscape.

Current Investment Strategy

KHP Capital Partners is actively managing KHP Fund VI, a discretionary equity fund currently comprising $300 million. This fund continues the firm’s commitment to investing in lifestyle hotels, with past funds witnessing substantial success, representing over $1.4 billion in equity for various hotel projects.

Recent Investments

Among recent developments is the Johnston Building, a notable project slated to open in late 2026 as a 240-room lifestyle hotel. Furthermore, KHP has acquired the historic Hotel Viking, which will undergo significant renovations. These acquisitions reflect the firm's strategic growth and dedication to enhancing the hospitality experience.

About KHP Capital Partners

KHP Capital Partners operates from the San Francisco Bay Area, focusing on lifestyle hotel investments that yield exceptional risk-adjusted returns. By adhering to disciplined acquisition strategies and leveraging their extensive experience, KHP seeks to drive growth and deliver value to its investors through innovative projects.

Frequently Asked Questions

Who is Ben Rowe?

Ben Rowe is the newly appointed CEO of KHP Capital Partners, also a Co-Founder and Managing Partner.

What is KHP Capital Partners known for?

KHP is recognized for its focus on investing in lifestyle hotels and its robust management of private equity funds.

What are recent projects by KHP Capital Partners?

Recent projects include the Johnston Building, set to open in 2026, and the acquisition of the Hotel Viking, currently undergoing renovations.

What is KHP Fund VI?

KHP Fund VI is a $300 million discretionary equity fund focused on investments in lifestyle hotels.

Where is KHP Capital Partners located?

KHP Capital Partners is headquartered in the San Francisco Bay Area and invests throughout the U.S.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Nonprofit and Partners Gift Homes to Veterans

Updated Category News Views 100

A Heartfelt Gesture on Veterans Day Now this is the kind of story that gets you right in the gut. On November 9, two veterans, who were likely walking into a golf club thinking it was just another evening, were handed the keys to a future they might have only dreamt of: a mortgage-free home. Operation Finally Home, backed by the big names like Lennar and the patriotic...

Continue Reading
Surprising Week on Wall Street: Chips Drive Gains

Updated Category News Views 141

A Wild Week in Wall Street Well, folks, what a week it’s been on Wall Street. The indexes danced the cha-cha, making gains despite closing Friday on a lower note. Despite the retreat, we've got ourselves a week where the major indexes closed higher than the previous Friday. It's not the usual story, but who ever thought stocks played by the rules? The Nasdaq Composite...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 141

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 83

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
LA Fitness ELEVATE Opens at RITHM: A New Era Dawns

Updated Category News Views 66

Elevating Fitness at RITHM: A New Era Has Begun RD Management just dropped a new ace in Tampa Bay’s hand—LA Fitness ELEVATE at the RITHM at Uptown. They lit up the scene with this 30,000-square-foot beast of a gym, and I’ll tell you, it’s not your standard run-of-the-mill joint. When you toss twelve-and-a-half million bucks into a pot, you're aiming to lure folks...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 99

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 155

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Gemmy's Holiday Lights: Bright Ideas for 2026

Updated Category News Views 149

Deep in the heart of Dallas, Gemmy Industries is out to sprinkle a bit of magic over the holiday season for 2026. This ain't your grandma's string lights we're talkin' about here. We're diving headfirst into a new world of seasonal decor with tech-driven lights that look like they came straight outta a winter wonderland. And hey, if Walmart's set to host this lineup, you...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 177

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading

Top 5 Most Recently Viewed Articles

NexPoint Capital Launches Tender Offer for Shareholders

Updated Category News Views 217

NexPoint Capital Begins Tender Offer for Its Common Stock NexPoint Capital, Inc. (the "Company"), a publicly registered business development company expertly managed by NexPoint Advisors, L.P., is set to kick off a voluntary tender offer aimed at going after up to 2.5% of its outstanding common shares. This offer is designed to provide shareholders an opportunity to sell...

Continue Reading
Experience the Winter Wheat Wonderland Pop-Up by Maker's Mark

Updated Category News Views 223

Immerse Yourself in Maker's Mark's Winter Wheat Wonderland Get ready to experience something truly unique this holiday season as Maker's Mark unveils its enchanting pop-up event, the Winter Wheat Wonderland. This special event will take the vibrant spirit of Kentucky bourbon to the heart of New York City, creating a magical atmosphere for all attendees. Details of the...

Continue Reading
Innovative Muscle Composition Study Enhances Liver Transplant Care

Updated Category News Views 202

Assessment of Muscle Composition in Liver Transplant Candidates In a groundbreaking study, the utilization of AMRA Profiler 4, an advanced body-composition analysis device, was analyzed for its effectiveness in evaluating muscle composition among liver transplant candidates suffering from end-stage liver disease (ESLD). This study aims to shed light on critical health...

Continue Reading
Hansa Biopharma's Major Milestones Anticipated in 2025

Updated Category News Views 688

Hansa Biopharma's Participation in Healthcare Conferences Hansa Biopharma AB, a pioneering biopharmaceutical company, is set to make a significant presence at the 2025 J.P. Morgan Healthcare Conference. The company is renowned for its innovative approaches in addressing rare immunological disorders and has been actively engaged in developing novel therapies. This...

Continue Reading
AI for Customer Service: The Next Big Market Leap Ahead

Updated Category News Views 137

AI for Customer Service Market Growth Overview The AI for customer service market is on a remarkable trajectory, set to expand significantly over the next few years. Current projections indicate that the market size will grow from USD 12.06 billion in the near term to an impressive USD 47.82 billion by the end of the decade, achieving a compound annual growth rate (CAGR)...

Continue Reading